Learnings from Throwing Paint at the Wall for COVID-19 with an SGLT2 Inhibitor.

Document Type

Article

Publication Date

5-1-2022

Publication Title

Clin J Am Soc Nephrol

Keywords

washington; spokane; covid-19; COVID-19; GFR; SARS-CoV-2; SGLT2; acute kidney injury; dapagliflozin; pandemic; safety; sodium-glucose cotransporter 2; Benzhydryl Compounds; COVID-19; Glucosides; Humans; Kidney; Paint; Sodium-Glucose Transporter 2 Inhibitors

Clinical Institute

Kidney & Diabetes

Department

Nephrology

Department

Infectious Diseases

Department

Endocrinology

Share

COinS